ADVERTISEMENT
Latest Blogs, Articles, and More
Experts Examine and Discuss the ER-Positive Breast Cancer Treatment Landscape
The management of patients with hormone receptor (HR)-positive breast cancer continues to evolve, with phase 3 studies shedding light on the length of adjuvant anti-estrogen therapy, a novel treatment gaining approval, and new trials exploring combination strategies.
We Are The 30%
Metastatic breast cancer will strike 30% of all breast cancer survivors yet only 2% of funds go to research this deadly cancer.
The Mechanics Of Inspiration
Being offered the chance to be an inspiration isn't up to you. What you do with it afterwards, is.
Eribulin Extends Survival in Phase 3 Sarcoma Study
Treatment with eribulin mesylate significantly extended overall survival (OS) compared with dacarbazine in patients with advanced soft tissue sarcoma, according to topline results from a phase 3 clinical trial.
Pipeline
The latest in cancer prevention, diagnosis & treatment.
Special Feature
ADVERTISEMENT
Recent Publications
  • photo
    photo
    photo
    photo
    photo
  • photo
    photo
    photo
    photo
    photo
ADVERTISEMENT
$auto_registration$